Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: A retrospective nationwide cohort study

Diabetologia

Volumn 53, Issue 12, 2010, Pages 2546-2553

  Andersson, C ^a   Olesen, J B ^a   Hansen, P R ^a   Weeke, P ^a   Norgaard, M L ^a   Jorgensen C H ^a   Lange, T ^b   Abildstrom S Z ^b,c   Schramm, T K ^b   Vaag, A ^d   Kober L ^b   Torp Pedersen, C ^a   Gislason, G H ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d STENO DIABETES CENTER   (Denmark)

Author keywords

Diabetes; Epidemiology; Glucose lowering drugs; Heart failure; Metformin; Outcomes; Pharmacotherapy

Indexed keywords

INSULIN; LOOP DIURETIC AGENT; METFORMIN; SULFONYLUREA;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DENMARK; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITALIZATION; HUMAN; LACTIC ACIDOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION;

AGED; AGED, 80 AND OVER; CAUSE OF DEATH; COHORT STUDIES; DENMARK; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; METFORMIN; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SULFONYLUREA COMPOUNDS; SURVIVAL ANALYSIS;

EID: 78649315767     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-010-1906-6     Document Type: Article

References (24)

1. E Ingelsson J Sundstrom J Arnlov B Zethelius L Lind 2005 Insulin resistance and risk of congestive heart failure Jama 294 334 341 1:CAS:528:DC%2BD2MXmtlGks7s%3D 10.1001/jama.294.3.334 16030278 (Pubitemid 41043777)
2. A Kalogeropoulos V Georgiopoulou TB Harris, et al. 2009 Glycemic status and incident heart failure in elderly without history of diabetes mellitus: the health, aging, and body composition study J Card Fail 15 593 599 1:CAS:528:DC%2BD1MXhtVehurrJ 10.1016/j.cardfail.2009.03.001 19700136
3. RM Witteles MB Fowler 2008 Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options J Am Coll Cardiol 51 93 102 1:CAS:528:DC%2BD1cXlsFCitg%3D%3D 10.1016/j.jacc.2007.10.021 18191731
4. ME Young P McNulty H Taegtmeyer 2002 Adaptation and maladaptation of the heart in diabetes: part II: potential mechanisms Circulation 105 1861 1870 1:CAS:528:DC%2BD38XjvFakt70%3D 10.1161/01.CIR.0000012467.61045.87 11956132 (Pubitemid 34408899)
5. M Domanski H Krause-Steinrauf P Deedwania, et al. 2003 The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial J Am Coll Cardiol 42 914 922 10.1016/S0735-1097(03)00856-8 12957443 (Pubitemid 37059754)
6. I Gustafsson B Brendorp M Seibaek, et al. 2004 Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure J Am Coll Cardiol 43 771 777 10.1016/j.jacc.2003.11.024 14998615 (Pubitemid 38296474)
7. WB Kannel M Hjortland WP Castelli 1974 Role of diabetes in congestive heart failure: the Framingham study Am J Cardiol 34 29 34 1:STN:280: DyaE2c3ltFKrug%3D%3D 10.1016/0002-9149(74)90089-7 4835750
8. T Kumler GH Gislason V Kirk, et al. 2008 Accuracy of a heart failure diagnosis in administrative registers Eur J Heart Fail 10 658 660 10.1016/j.ejheart.2008.05.006 18539522
9. D Gaist HT Sorensen J Hallas 1997 The Danish prescription registries Dan Med Bull 44 445 448 1:STN:280:DyaK1c%2FhslKlug%3D%3D 9377907
10. GH Gislason JN Rasmussen SZ Abildstrom, et al. 2007 Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes Circulation 116 737 744 10.1161/CIRCULATIONAHA.106.669101 17646585 (Pubitemid 47255991)
11. EL Fosbol GH Gislason S Jacobsen, et al. 2009 Risk of myocardial infarction and death associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study Clin Pharmacol Ther 85 190 197 1:STN:280:DC%2BD1M%2FosVSltw%3D%3D 10.1038/clpt.2008.204 18987620
12. GH Gislason JN Rasmussen SZ Abildstrom, et al. 2006 Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction Eur Heart J 27 1153 1158 1:CAS:528: DC%2BD28Xls1Crt7o%3D 10.1093/eurheartj/ehi705 16399775
13. S Eshaghian TB Horwich GC Fonarow 2006 Relation of loop diuretic dose to mortality in advanced heart failure The Am J Cardiol 97 1759 1764 1:CAS:528:DC%2BD28XlsVeltL0%3D 10.1016/j.amjcard.2005.12.072 (Pubitemid 43817867)
14. ME Charlson P Pompei KL Ales CR MacKenzie 1987 A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 373 383 1:STN:280:DyaL2s7ms1GnsQ%3D%3D 10.1016/0021-9681(87)90171-8 3558716 (Pubitemid 17055592)
15. LD Fisher DY Lin 1999 Time-dependent covariates in the Cox proportional-hazards regression model Annu Rev Public Health 20 145 157 1:STN:280:DyaK1M3otFWhsg%3D%3D 10.1146/annurev.publhealth.20.1.145 10352854 (Pubitemid 29242575)
16. DT Eurich FA McAlister DF Blackburn, et al. 2007 Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review BMJ 335 497 1:CAS:528:DC%2BD2sXhtFOntr%2FE 10.1136/bmj.39314.620174.80 17761999 (Pubitemid 47401611)
17. FA Masoudi SE Inzucchi Y Wang EP Havranek JM Foody HM Krumholz 2005 Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study Circulation 111 583 590 1:CAS:528:DC%2BD2MXovFKhsw%3D%3D 10.1161/01.CIR.0000154542.13412.B1 15699279 (Pubitemid 40216485)
18. DM Nathan JB Buse MB Davidson, et al. 2009 Medical management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes Diabetologia 52 17 30 1:STN:280:DC%2BD1cjotVGitQ%3D%3D 10.1007/s00125-008-1157-y 18941734
19. R Khurana IS Malik 2010 Metformin: safety in cardiac patients Heart 96 99 102 1:CAS:528:DC%2BC3cXislWhs7o%3D 19564648
20. AA Tahrani GI Varughese JH Scarpello FW Hanna 2007 Metformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated? BMJ 335 508 512 1:CAS:528:DC%2BD2sXhtFOntr%2FF 10.1136/bmj.39255.669444.AE 17823192 (Pubitemid 47401613)
21. S Gundewar JW Calvert S Jha, et al. 2009 Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure Circ Res 104 403 411 1:CAS:528:DC%2BD1MXhsV2jsLY%3D 10.1161/CIRCRESAHA.108.190918 19096023
22. H Sasaki H Asanuma M Fujita, et al. 2009 Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase Circulation 119 2568 2577 1:CAS:528:DC%2BD1MXmtVKntrg%3D 10.1161/CIRCULATIONAHA.108.798561 19414638
23. DT Eurich RT Tsuyuki SR Majumdar, et al. 2009 Metformin treatment in diabetes and heart failure: when academic equipoise meets clinical reality Trials 10 12 10.1186/1745-6215-10-12 19203392
24. C Andersson P Weeke R Pecini, et al. 2010 Long-term impact of diabetes in patients hospitalized with ischemic and non-ischemic heart failure Scand Cardiovasc J 44 37 44 10.3109/14017430903312438 19878095